# Folate Cognition Randomized Trial: What the Evidence Says
Canonical: https://www.migaku.app/guides/folate-cognition-randomized-trial-evidence-review
Category: evidence-review
Summary: Folate Cognition Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are rando
Last reviewed: 2026-06-25
Reviewed by: Migaku Evidence Review
# Folate Cognition Randomized Trial: What the Evidence Says

## Quick Answer

Folate Cognition Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are randomized trial, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 1 randomized trial, 1 narrative review.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| Genetic Variation in Response to the Mediterranean–DASH Intervention for Neurodegenerative Delay (MIND): A Randomized Controlled Trial | randomized trial | 2 | 2026-02-02 | 10.3390/nu18030508 |
| The role of nutrition and multimodal lifestyle interventions in Alzheimer's prevention and management: a mini-review. | narrative review | 3 | 2026-04-08 | 10.3389/fnut.2026.1818913 |

## What The Sources Report

- Table S1 3 4 5 6 The Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) diet is based on the most compelling evidence in the diet-dementia field. [Cornelis Marilyn C. (2026); evidence level 2]
- Population studies suggest adherence to the diet may slow the rate of cognitive decline and decrease the risk of dementia. [Cornelis Marilyn C. (2026); evidence level 2]
- This mini-review synthesizes current evidence on dietary and lifestyle interventions for AD prevention and management from randomized controlled trials (RCTs) and observational studies. [Zhang H (2026); evidence level 3]
- Current findings indicate that multidomain approaches, such as the Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) diet and the Finnish Geriatric Intervention Study (FINGER) model, which integrate nutrition, physical activity, and cognitive training, consistently demonstrate efficacy in slowing cognitive decline and reducing brain atrophy in at-risk elderly populations. [Zhang H (2026); evidence level 3]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

There is trial evidence in the current set, but population and intervention details still matter. For folate cognition randomized trial, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Cornelis Marilyn C. (2026). Genetic Variation in Response to the Mediterranean–DASH Intervention for Neurodegenerative Delay (MIND): A Randomized Controlled Trial. DOI: 10.3390/nu18030508. PMCID: PMC12899571. PMID: 41683330. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12899571/
- Zhang H (2026). The role of nutrition and multimodal lifestyle interventions in Alzheimer's prevention and management: a mini-review.. DOI: 10.3389/fnut.2026.1818913. PMCID: PMC13099917. PMID: 42027570. https://pmc.ncbi.nlm.nih.gov/articles/PMC13099917/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.